Inventor
COSTANTINO PAOLO
IT35 patents
⚠️ This page may combine multiple inventors who share the name “COSTANTINO PAOLO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
COSTANTINO PAOLO
13 patentsUS8889152B2Nov 18, 2014
Capsular polysaccharides solubilisation and combination vaccines
COSTANTINO PAOLO10 citations92
US8753651B2Jun 17, 2014
Capsular polysaccharide solubilisation and combination vaccines
COSTANTINO PAOLO16 citations92
US9782467B2Oct 10, 2017
Capsular polysaccharide solubilisation and combination vaccines
COSTANTINO PAOLO6 citations84
US9492558B2Nov 15, 2016
Combined meningococcal conjugates with common carrier protein
COSTANTINO PAOLO8 citations84
US9452207B2Sep 27, 2016
Capsular polysaccharide solubilisation and combination vaccines
COSTANTINO PAOLO4 citations84
US9060965B2Jun 23, 2015
Purification of Staphylococcus aureus type 5 capsular saccharides
COSTANTINO PAOLO8 citations83
US10272147B2Apr 30, 2019
Injectable vaccines against multiple meningococcal serogroups
COSTANTINO PAOLO1 citations73
US9358278B2Jun 7, 2016
Capsular polysaccharide solubilisation and combination vaccines
COSTANTINO PAOLO2 citations62
US8852606B2Oct 7, 2014
Capsular polysaccharide solubilisation and combination vaccines
COSTANTINO PAOLO2 citations62
US9173954B2Nov 3, 2015
Polysaccharide immunogens conjugated to E. coli carrier proteins
COSTANTINO PAOLO3 citations57
US8445239B2May 21, 2013
Fermentation processes for cultivating streptococci and purification processes for obtaining CPS therefrom
COSTANTINO PAOLO2 citations56
US11065323B2Jul 20, 2021
Purification method
COSTANTINO PAOLO0 citations48
US9243271B2Jan 26, 2016
Fermentation processes for cultivating Streptococci and purification processes for obtaining cps therefrom
COSTANTINO PAOLO0 citations45
GLAXOSMITHKLINE BIOLOGICALS SA
9 patentsUS9441004B2Sep 13, 2016
Purification of staphylococcus aureus type 8 capsular saccharides
GLAXOSMITHKLINE BIOLOGICALS SA5 citations83
US10668142B2Jun 2, 2020
Injectable vaccines against multiple meningococcal serogroups
GLAXOSMITHKLINE BIOLOGICALS SA2 citations73
US9839686B2Dec 12, 2017
Conjugation of Staphylococcus aureus type 8 capsular polysaccharides
GLAXOSMITHKLINE BIOLOGICALS SA4 citations72
US11208424B2Dec 28, 2021
Staphylococcus aureus type 5 capsular saccharides
GLAXOSMITHKLINE BIOLOGICALS SA0 citations62
US10716841B2Jul 21, 2020
Capsular polysaccharide solubilisation and combination vaccines
GLAXOSMITHKLINE BIOLOGICALS SA0 citations52
US9981031B2May 29, 2018
Injectable vaccines against multiple meningococcal serogroups
GLAXOSMITHKLINE BIOLOGICALS SA0 citations52
US10736959B2Aug 11, 2020
Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
GLAXOSMITHKLINE BIOLOGICALS SA0 citations51
US10172928B2Jan 8, 2019
Purification of streptococcal capsular polysaccharide
GLAXOSMITHKLINE BIOLOGICALS SA0 citations51
US10668143B2Jun 2, 2020
Meningococcus serogroup X conjugate
GLAXOSMITHKLINE BIOLOGICALS SA0 citations50
NOVARTIS AG
5 patentsUS9827301B2Nov 28, 2017
Hypo- and hyper-acetylated meningococcal capsular saccharides
NOVARTIS AG2 citations73
US9493517B2Nov 15, 2016
Conjugates comprising an antigen and a carrier molecule
NOVARTIS AG5 citations72
US10124051B2Nov 13, 2018
Meningococcus serogroup X conjugate
NOVARTIS AG2 citations71
US9475846B2Oct 25, 2016
Conjugated Vi saccharides
NOVARTIS AG0 citations51
US9439955B2Sep 13, 2016
Conjugated β-1,3-linked glucans
NOVARTIS AG0 citations51